These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23044104)

  • 41. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
    Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
    Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development and evaluation of novel microemulsion based oral formulations of 5-fluorouracil using non-everted rat intestine sac model.
    Shishu ; Kamalpreet ; Maheshwari M
    Drug Dev Ind Pharm; 2012 Mar; 38(3):294-300. PubMed ID: 21864111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.
    Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Matson VZ; Steeber DA; Gong S
    ACS Nano; 2010 Nov; 4(11):6805-17. PubMed ID: 20958084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chitosan-Carboxymethyl-5-Fluorouracil-Folate Conjugate Particles: Microwave Modulated Uptake by Skin and Melanoma Cells.
    Nawaz A; Wong TW
    J Invest Dermatol; 2018 Nov; 138(11):2412-2422. PubMed ID: 29857069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new healthy sunscreen system for human: solid lipid nanoparticles as carrier for 3,4,5-trimethoxybenzoylchitin and the improvement by adding Vitamin E.
    Song C; Liu S
    Int J Biol Macromol; 2005 Jul; 36(1-2):116-9. PubMed ID: 16005509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization--in-vitro drug release and anti-tumour activity.
    Yan C; Chen D; Gu J; Qin J
    J Pharm Pharmacol; 2006 Sep; 58(9):1177-81. PubMed ID: 16945175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selenium nanoparticles as a carrier of 5-fluorouracil to achieve anticancer synergism.
    Liu W; Li X; Wong YS; Zheng W; Zhang Y; Cao W; Chen T
    ACS Nano; 2012 Aug; 6(8):6578-91. PubMed ID: 22823110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs.
    Lu J; Liong M; Zink JI; Tamanoi F
    Small; 2007 Aug; 3(8):1341-6. PubMed ID: 17566138
    [No Abstract]   [Full Text] [Related]  

  • 49. Poly(L-aspartic acid) nanogels for lysosome-selective antitumor drug delivery.
    Oh NM; Oh KT; Youn YS; Lee DK; Cha KH; Lee DH; Lee ES
    Colloids Surf B Biointerfaces; 2013 Jan; 101():298-306. PubMed ID: 23010033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5-Fluorouracil-loaded multilayered films for drug controlled releasing stent application: Drug release, microstructure, and ex vivo permeation behaviors.
    Lei L; Liu X; Guo S; Tang M; Cheng L; Tian L
    J Control Release; 2010 Aug; 146(1):45-53. PubMed ID: 20566400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and antitumor activity of conjugates of 5-Fluorouracil and emodin.
    Zhao LM; Zhang LM; Liu JJ; Wan LJ; Chen YQ; Zhang SQ; Yan ZW; Jiang JH
    Eur J Med Chem; 2012 Jan; 47(1):255-60. PubMed ID: 22093761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Release behaviour of 5-fluorouracil from chitosan-gel microspheres immobilizing 5-fluorouracil derivative coated with polysaccharides and their cell specific recognition.
    Ohya Y; Takei T; Kobayashi H; Ouchi T
    J Microencapsul; 1993; 10(1):1-9. PubMed ID: 8383199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanoparticles for topical drug delivery: Potential for skin cancer treatment.
    Krishnan V; Mitragotri S
    Adv Drug Deliv Rev; 2020 Jan; 153():87-108. PubMed ID: 32497707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The molecular effects of aloe-emodin (AE)/liposome-AE on human nonmelanoma skin cancer cells and skin permeation.
    Chou TH; Liang CH
    Chem Res Toxicol; 2009 Dec; 22(12):2017-28. PubMed ID: 19928967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibody-targeted nanovectors for the treatment of brain cancers.
    Sharpe MA; Marcano DC; Berlin JM; Widmayer MA; Baskin DS; Tour JM
    ACS Nano; 2012 Apr; 6(4):3114-20. PubMed ID: 22390360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
    Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
    Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 5-Fluorouracil ethosomes - skin deposition and melanoma permeation synergism with microwave.
    Khan NR; Wong TW
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):568-577. PubMed ID: 29378453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apoptosis induced by 5-fluorouracil, cisplatin and paclitaxel are associated with p53 gene status in gastric cancer cell lines.
    Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
    Int J Oncol; 2005 Jun; 26(6):1563-7. PubMed ID: 15870870
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential effects of 5-fluorouracil on human skin melanocytes and malignant melanoma cells in vitro.
    Tsuji T; Karasek MA
    Acta Derm Venereol; 1986; 66(6):474-8. PubMed ID: 2433865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice.
    Singh P; Gupta U; Asthana A; Jain NK
    Bioconjug Chem; 2008 Nov; 19(11):2239-52. PubMed ID: 18950215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.